Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
166 hedge funds and large institutions have $2.32B invested in Silk Road Medical, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 45 increasing their positions, 75 reducing their positions, and 20 closing their positions.
369% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $2.61M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
61% more capital invested
Capital invested by funds: $1.44B → $2.32B (+$881M)
60% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 20
8% more funds holding
Funds holding: 154 → 166 (+12)
40% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$45.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$43.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$24.2M |
| 4 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$18.8M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$31.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$24.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$18.8M |
| 4 |
Jennison Associates
New York
|
-$15.3M |
| 5 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$13.6M |
SILK Hedge Fund Activity: Q3 2020 in Review
166 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2020, worth a combined $2.32B — up 61% from $1.44B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new SILK positions and 20 closed out — a net gain of 12 holders — while 45 added to existing stakes and 75 trimmed.
The largest buyer was Matrix Capital Management Company, opening a new position worth an estimated $45.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $31.2M sold.
- 166 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2020, up from 154 in Q2 2020.
- Funds reported $2.32B of Silk Road Medical, Inc. Common Stock stock for Q3 2020, up 61% quarter-over-quarter.
- 32 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2020 and 20 closed out, a net change of +12 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2020 was Matrix Capital Management Company, an estimated $45.8M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q3 2020 was Deerfield Management, an estimated $31.2M sold.
Based on aggregated 13F filings for Q3 2020.